Literature DB >> 23607450

Epstein-Barr virus patterns in US Burkitt lymphoma tumors from the SEER residual tissue repository during 1979-2009.

Sam M Mbulaiteye1, Sheeja T Pullarkat, Bharat N Nathwani, Lawrence M Weiss, Nagesh Rao, Benjamin Emmanuel, Charles F Lynch, Brenda Hernandez, Vishala Neppalli, Debra Hawes, Myles G Cockburn, Andre Kim, Makeda Williams, Sean Altekruse, Kishor Bhatia, Marc T Goodman, Wendy Cozen.   

Abstract

Burkitt lymphoma (BL) occurs at all ages, but the patterns of Epstein-Barr virus (EBV) positivity in relation to human immunodeficiency virus (HIV), immunoprofiles and age have not been fully explored. BL tissues from residual tissue repositories, and two academic centers in the United States were examined by expert hematopathologists for morphology, immunohistochemistry, MYC rearrangement, EBV-encoded RNA (EBER), and diagnosed according to the 2008 WHO lymphoma classification. Analysis was done using frequency tables, Chi-squared statistics, and Student's t-test. Of 117 cases examined, 91 were confirmed as BL. The age distribution was 26%, 15%, 19%, and 29% for 0-19, 20-34, 35-59, 60+ years, and missing in 11%. MYC rearrangement was found in 89% and EBER positivity in 29% of 82 cases with results. EBER positivity varied with age (from 13% in age group 0-19 to 55% in age group 20-34, and fell to 25% in age group 60+ years, p = 0.08); with race (56% in Blacks/Hispanics vs 21% in Whites/Asians/Pacific Islanders, p = 0.006); and by HIV status (64% in HIV positive vs 22% in HIV negative cases, p = 0.03). EBER positivity was demonstrated in about one-third of tumors and it was strongly associated with race and HIV status, and marginally with age-group.
© 2013 APMIS Published by Blackwell Publishing Ltd.

Entities:  

Keywords:  Africa; HIV/AIDS; MYC; Non-hodgkin lymphoma; burkitt lymphoma; epstein-barr virus

Mesh:

Substances:

Year:  2013        PMID: 23607450      PMCID: PMC3723754          DOI: 10.1111/apm.12078

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  33 in total

1.  Epstein-Barr virus in an American patient with Burkitt's lymphoma: detection of viral genome in tumor tissue and establishment of a tumor-derived cell line (NAB).

Authors:  M Gravell; P H Levine; R F McIntyre; V J Land; J S Pagano
Journal:  J Natl Cancer Inst       Date:  1976-04       Impact factor: 13.506

2.  Diagnosis of Burkitt lymphoma using an algorithmic approach--applicable in both resource-poor and resource-rich countries.

Authors:  Kikkeri N Naresh; Hazem A H Ibrahim; Stefano Lazzi; Patricia Rince; Monica Onorati; Maria R Ambrosio; Chrystèle Bilhou-Nabera; Furrat Amen; Alistair Reid; Michael Mawanda; Valeria Calbi; Martin Ogwang; Emily Rogena; Bessie Byakika; Shahin Sayed; Emma Moshi; Amos Mwakigonja; Martine Raphael; Ian Magrath; Lorenzo Leoncini
Journal:  Br J Haematol       Date:  2011-07-01       Impact factor: 6.998

3.  Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes.

Authors:  Lisa Giulino-Roth; Kai Wang; Theresa Y MacDonald; Susan Mathew; Yifang Tam; Maureen T Cronin; Gary Palmer; Norma Lucena-Silva; Francisco Pedrosa; Marcia Pedrosa; Julie Teruya-Feldstein; Govind Bhagat; Bachir Alobeid; Lorenzo Leoncini; Cristiana Bellan; Emily Rogena; Kerice A Pinkney; Mark A Rubin; Raul C Ribeiro; Roman Yelensky; Wayne Tam; Philip J Stephens; Ethel Cesarman
Journal:  Blood       Date:  2012-10-22       Impact factor: 22.113

4.  Absence of Epstein-Barr viral DNA in Amercian Burkitt's lymphoma.

Authors:  J S Pagano; C H Huang; P Levine
Journal:  N Engl J Med       Date:  1973-12-27       Impact factor: 91.245

5.  Infectious mononucleosis: epidemiologic patterns at United States colleges and universities.

Authors:  A L Brodsky; C W Heath
Journal:  Am J Epidemiol       Date:  1972-08       Impact factor: 4.897

6.  Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis.

Authors:  Sandrine Sander; Dinis P Calado; Lakshmi Srinivasan; Karl Köchert; Baochun Zhang; Maciej Rosolowski; Scott J Rodig; Karlheinz Holzmann; Stephan Stilgenbauer; Reiner Siebert; Lars Bullinger; Klaus Rajewsky
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

7.  Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression.

Authors:  Stella Pelengaris; Michael Khan; Gerard I Evan
Journal:  Cell       Date:  2002-05-03       Impact factor: 41.582

8.  Pediatric, elderly, and emerging adult-onset peaks in Burkitt's lymphoma incidence diagnosed in four continents, excluding Africa.

Authors:  Sam M Mbulaiteye; William F Anderson; Jacques Ferlay; Kishor Bhatia; Cindy Chang; Philip S Rosenberg; Susan S Devesa; Donald M Parkin
Journal:  Am J Hematol       Date:  2012-04-10       Impact factor: 10.047

Review 9.  Viruses and Hodgkin's lymphoma.

Authors:  R F Jarrett
Journal:  Ann Oncol       Date:  2002       Impact factor: 32.976

10.  Detection of Epstein-Barr virus DNA in American Burkitt's lymphoma.

Authors:  J L Ziegler; G Klein; W Henle
Journal:  Int J Cancer       Date:  1976-06-15       Impact factor: 7.396

View more
  9 in total

Review 1.  Epstein-Barr virus in the pathogenesis of oral cancers.

Authors:  J T Guidry; C E Birdwell; R S Scott
Journal:  Oral Dis       Date:  2017-04-18       Impact factor: 3.511

2.  Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink.

Authors:  Parisa Karimi; Brenda M Birmann; Lesley A Anderson; Charlene M McShane; Shahinaz M Gadalla; Joshua N Sampson; Sam M Mbulaiteye
Journal:  Br J Haematol       Date:  2018-04-20       Impact factor: 6.998

Review 3.  SEER cancer registry biospecimen research: yesterday and tomorrow.

Authors:  Sean F Altekruse; Gabriel E Rosenfeld; Danielle M Carrick; Emilee J Pressman; Sheri D Schully; Leah E Mechanic; Kathleen A Cronin; Brenda Y Hernandez; Charles F Lynch; Wendy Cozen; Muin J Khoury; Lynne T Penberthy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12       Impact factor: 4.254

4.  Medical history, lifestyle, family history, and occupational risk factors for sporadic Burkitt lymphoma/leukemia: the Interlymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Sam M Mbulaiteye; Lindsay M Morton; Joshua N Sampson; Ellen T Chang; Laura Costas; Silvia de Sanjosé; Tracy Lightfoot; Jennifer Kelly; Jonathan W Friedberg; Wendy Cozen; Rafael Marcos-Gragera; Susan L Slager; Brenda M Birmann; Dennis D Weisenburger
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

Review 5.  How do viruses trick B cells into becoming lymphomas?

Authors:  Ethel Cesarman
Journal:  Curr Opin Hematol       Date:  2014-07       Impact factor: 3.284

6.  Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma.

Authors:  Bruno M Grande; Daniela S Gerhard; Aixiang Jiang; Nicholas B Griner; Jeremy S Abramson; Thomas B Alexander; Hilary Allen; Leona W Ayers; Jeffrey M Bethony; Kishor Bhatia; Jay Bowen; Corey Casper; John Kim Choi; Luka Culibrk; Tanja M Davidsen; Maureen A Dyer; Julie M Gastier-Foster; Patee Gesuwan; Timothy C Greiner; Thomas G Gross; Benjamin Hanf; Nancy Lee Harris; Yiwen He; John D Irvin; Elaine S Jaffe; Steven J M Jones; Patrick Kerchan; Nicole Knoetze; Fabio E Leal; Tara M Lichtenberg; Yussanne Ma; Jean Paul Martin; Marie-Reine Martin; Sam M Mbulaiteye; Charles G Mullighan; Andrew J Mungall; Constance Namirembe; Karen Novik; Ariela Noy; Martin D Ogwang; Abraham Omoding; Jackson Orem; Steven J Reynolds; Christopher K Rushton; John T Sandlund; Roland Schmitz; Cynthia Taylor; Wyndham H Wilson; George W Wright; Eric Y Zhao; Marco A Marra; Ryan D Morin; Louis M Staudt
Journal:  Blood       Date:  2019-01-07       Impact factor: 25.476

Review 7.  Epstein-Barr virus and Burkitt lymphoma.

Authors:  Martin Rowe; Leah Fitzsimmons; Andrew I Bell
Journal:  Chin J Cancer       Date:  2014-11-21

8.  Burkitt Lymphoma: beyond discoveries.

Authors:  Sam M Mbulaiteye
Journal:  Infect Agent Cancer       Date:  2013-09-30       Impact factor: 2.965

9.  MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs.

Authors:  C David Wood; Hildegonda Veenstra; Sarika Khasnis; Andrea Gunnell; Helen M Webb; Claire Shannon-Lowe; Simon Andrews; Cameron S Osborne; Michelle J West
Journal:  Elife       Date:  2016-08-04       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.